Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Drug Discovery Today|October 4, 2011
A challenging drug development process in the era of personalized medicineJan Trøst JørgensenAnnals of Translational Medicine|June 24, 2024
Twenty-five years with HER2 targeted therapyJan Trøst JørgensenChinese Clinical Oncology|November 12, 2023
Twenty-five years with companion diagnosticsJan Trøst JørgensenExpert Review of Molecular Diagnostics|January 20, 2015
Companion diagnostics: the key to personalized medicine. ForewordJan Trøst JørgensenTranslational Oncology|March 14, 2021
The current landscape of the FDA approved companion diagnosticsJan Trøst JørgensenExpert Review of Molecular Diagnostics|November 13, 2015
Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLCJan Trøst JørgensenTrends in Cancer|July 26, 2017
Companion and Complementary Diagnostics: Clinical and Regulatory PerspectivesJan Trøst JørgensenJCO Precision Oncology|June 16, 2022
Missing Companion Diagnostic for US Food and Drug Administration-Approved Hematological and Oncological DrugsJan Trøst JørgensenWorld Journal of Gastroenterology|May 1, 2014
Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspectsJan Trøst JørgensenOncology|August 31, 2023
The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic DrugJan Trøst JørgensenPageof 5